Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1573265rdf:typepubmed:Citationlld:pubmed
pubmed-article:1573265lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:1573265lifeskim:mentionsumls-concept:C0020731lld:lifeskim
pubmed-article:1573265lifeskim:mentionsumls-concept:C0524637lld:lifeskim
pubmed-article:1573265lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:1573265lifeskim:mentionsumls-concept:C0021024lld:lifeskim
pubmed-article:1573265lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:1573265pubmed:issue9lld:pubmed
pubmed-article:1573265pubmed:dateCreated1992-6-2lld:pubmed
pubmed-article:1573265pubmed:abstractTextWe have examined the role of 12 polymorphic residues of the beta-chain of the HLA-DR1 class II molecule in T cell recognition of an epitope of pertussis toxin. Murine L cell transfectants expressing wild-type or mutant DR1 molecules (containing single amino acid substitutions in DR(beta 1*0101)) were used as APC in proliferation assays involving nine DR1-restricted T cell clones specific for peptide 30-42 of pertussis toxin. Four different patterns of recognition of the mutants were found among the pertussis-specific clones. Residues in the third hypervariable region (HVR) of DR(beta 1*0101) are critically important for all the T cell clones; amino acid substitutions at positions 70 and 74 abrogated recognition by all of the T cell clones, and substitutions at positions 67 and 71 eliminated recognition by most of the clones. In contrast, most single amino acid substitutions in the first and second HVR, predicted to be located in the floor of the peptide binding groove, had little or no effect on the proliferative responses of these clones. However, the involvement of beta-chain first and second HVR residues was demonstrated by the inability of transfectants expressing wild-type DR(beta 1*0404) (DR4Dw14) or DR(beta 1*1402) (DR6Dw16) to present peptide to these clones. These beta-chains have completely different first and second HVR compared with DR(alpha,beta 1*0101) although the third HVR are identical. These results illustrate the functional importance of third HVR residues of DR(beta 1*0101) and allow definition of the molecular interactions of the DR1 molecule with the 30-42 peptide.lld:pubmed
pubmed-article:1573265pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:languageenglld:pubmed
pubmed-article:1573265pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1573265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1573265pubmed:statusMEDLINElld:pubmed
pubmed-article:1573265pubmed:monthMaylld:pubmed
pubmed-article:1573265pubmed:issn0022-1767lld:pubmed
pubmed-article:1573265pubmed:authorpubmed-author:KarrR WRWlld:pubmed
pubmed-article:1573265pubmed:authorpubmed-author:Di TommasoAAlld:pubmed
pubmed-article:1573265pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:1573265pubmed:authorpubmed-author:OlsonR RRRlld:pubmed
pubmed-article:1573265pubmed:issnTypePrintlld:pubmed
pubmed-article:1573265pubmed:day1lld:pubmed
pubmed-article:1573265pubmed:volume148lld:pubmed
pubmed-article:1573265pubmed:ownerNLMlld:pubmed
pubmed-article:1573265pubmed:authorsCompleteYlld:pubmed
pubmed-article:1573265pubmed:pagination2703-8lld:pubmed
pubmed-article:1573265pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:meshHeadingpubmed-meshheading:1573265-...lld:pubmed
pubmed-article:1573265pubmed:year1992lld:pubmed
pubmed-article:1573265pubmed:articleTitleMutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.lld:pubmed
pubmed-article:1573265pubmed:affiliationDepartment of Veterans Affairs Medical Center, Iowa City, IA.lld:pubmed
pubmed-article:1573265pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1573265pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1573265pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:1573265pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1573265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1573265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1573265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1573265lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1573265lld:pubmed